Finzati - Logo
LTRN logo

Lantern Pharma Inc.

LTRN • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$33.81M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 2.4Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:14 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$33.81M
52W Range1.11 - 4.75
Beta2.34
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio2.40
Quick Ratio2.40
Volume165.59K

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 2.4Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/11/2020
Industry: Biotechnology
P/B i: 0.01
Debt / Equity i: 0.01
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 2.40
Quick Ratio: 2.40
Status: Good

Insider Transactions

Recent executive and insider activity

KEYSER D JEFFREY
Transaction: 05/12/2026
SELL
Change
-48,544
Price
$2.27
Filing
05/14/2026
Type
SELL
KEYSER D JEFFREY
Transaction: 05/12/2026
BUY
Change
+48,544
Price
$2.06
Filing
05/14/2026
Type
BUY
Schalop Lee Troy
Transaction: 05/12/2026
BUY
Change
+48,544
Price
$2.06
Filing
05/14/2026
Type
BUY